Ann: ReNerve - Investor Presentation, page-3

  1. 2,878 Posts.
    lightbulb Created with Sketch. 465
    A lot to like about this one - not as sexy as some medical companies products or potential subject to subject to subject trials products

    By contrast RNV has one product already in place with full US approval's and already being used/sold and a clear pipeline for 2 other very good products to be approved in good/quick time

    A slow burner but looks like a very good story (DYOR off course)
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
11.0¢
Change
0.010(10.0%)
Mkt cap ! $11.57M
Open High Low Value Volume
10.0¢ 11.0¢ 10.0¢ $559 5.114K

Buyers (Bids)

No. Vol. Price($)
2 5185 10.5¢
 

Sellers (Offers)

Price($) Vol. No.
11.0¢ 45523 1
View Market Depth
Last trade - 13.57pm 28/07/2025 (20 minute delay) ?
RNV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.